The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Transcriptional Repression by Blimp-1 (PRDI-BF1) Involves Recruitment of Histone Deacetylase
Open accessAbstract
B-lymphocyte-induced maturation protein (Blimp-1) is a transcriptional repressor that is considered to be a master regulator of terminal B-cell development because it is sufficient to trigger differentiation in the BCL(1)-cell model. Transcription of the c-myc gene is repressed by Blimp-1 during B-cell differentiation. In this study, we have explored the mechanism by which Blimp-1 represses transcription by using Gal4-fusion protein assays and assays in which Blimp-1 represses the natural c-myc promoter. The results show that Blimp-1 represses the c-myc promoter by an active mechanism that is independent of the adjacently bound activator YY1. Blimp-1 contains two regions that independently associate with histone deacetylase (HDAC) and endogenous Blimp-1 in nuclear extracts binds in vitro to the c-myc Blimp-1 site in a complex containing HDAC. The functional importance of recruiting HDAC for Blimp-1-dependent repression of c-myc transcription is supported by two experiments. First, the HDAC inhibitor tricostatin A inhibits Blimp-1-dependent repression in cotransfection assays. Second, a chromatin immunoprecipitation assay shows that expression of Blimp-1 causes deacetylation of histone H3 associated with the c-myc promoter, and this deacetylation depends on the Blimp-1 binding site in the c-myc promoter.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Histone acetylation in chromatin structure and transcription
Grunstein, M. (1997) · Nature · doi:10.1038/38664 · Cited by 2,884 · cited 13×
“Our work shows that for Blimp-1, like several other transcriptional repressors (16, 48, 64), HDAC activity is important for transcriptional repression.”
BackgroundInfluentialYoshida, M., Kijima, M., Akita, M., & Beppu, T. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44885-x · Cited by 1,854
A Mammalian Histone Deacetylase Related to the Yeast Transcriptional Regulator Rpd3p
Taunton, J., Hassig, C. A., & Schreiber, S. L. (1996) · Science · doi:10.1126/science.272.5260.408 · Cited by 1,829 · cited 1×
“To test this hypothesis, we first measured the ability of GAL4DBD-Blimp-1 fusion proteins to repress the (Gal4)4-tk promoter in the presence of TSA, an inhibitor of HDAC activity (60, 68).”
BackgroundGuan, K., & Dixon, J. E. (1991) · Analytical Biochemistry · doi:10.1016/0003-2697(91)90534-z · Cited by 1,746
Nuclear Receptor Repression Mediated by a Complex Containing SMRT, mSin3A, and Histone Deacetylase
Nagy, L., Kao, H.-Y., Chakravarti, D., Lin, R. J., Hassig, C. A., Ayer, D. E., Schreiber, S. L., & Evans, R. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80218-4 · Cited by 1,230
A complex containing N-CoR, mSln3 and histone deacetylase mediates transcriptional repression
Heinzel, T., Lavinsky, R. M., Mullen, T.-M., Söderström, M., Laherty, C. D., Torchia, J., Yang, W.-M., Brard, G., Ngo, S. D., Davie, J. R., et al. (1997) · Nature · doi:10.1038/387043a0 · Cited by 1,214
Zhong, H., Voll, R. E., & Ghosh, S. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80066-0 · Cited by 1,210
Role of the histone deacetylase complex in acute promyelocytic leukaemia
Lin, R. J., Nagy, L., Inoue, S., Shao, W., Miller, W. H., & Evans, R. M. (1998) · Nature · doi:10.1038/35895 · Cited by 1,062
Grignani, F., De Matteis, S., Nervi, C., Tomassoni, L., Gelmetti, V., Cioce, M., Fanelli, M., Ruthardt, M., Ferrara, F. F., Zamir, I., et al. (1998) · Nature · doi:10.1038/35901 · Cited by 1,004
Rb Interacts with Histone Deacetylase to Repress Transcription
Luo, R. X., Postigo, A. A., & Dean, D. C. (1998) · Cell · doi:10.1016/s0092-8674(00)80940-x · Cited by 960
Cited by
THE MAMMALIAN UNFOLDED PROTEIN RESPONSE
Schröder, M., & Kaufman, R. J. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.074134 · Cited by 3,026
Plasma cell differentiation requires the transcription factor XBP-1
Reimold, A. M., Iwakoshi, N. N., Manis, J., Vallabhajosyula, P., Szomolanyi-Tsuda, E., Gravallese, E. M., Friend, D., Grusby, M. J., Alt, F., & Glimcher, L. H. (2001) · Nature · doi:10.1038/35085509 · Cited by 1,305
Shaffer, A. L., Lin, K.-I., Kuo, T. C., Yu, X., Hurt, E. M., Rosenwald, A., Giltnane, J. M., Yang, L., Zhao, H., Calame, K., et al. (2002) · Immunity · doi:10.1016/s1074-7613(02)00335-7 · Cited by 1,047
Self-citationCompetence and competition: the challenge of becoming a long-lived plasma cell
Radbruch, A., Muehlinghaus, G., Luger, E. O., Inamine, A., Smith, K. G. C., Dörner, T., & Hiepe, F. (2006) · Nature Reviews Immunology · doi:10.1038/nri1886 · Cited by 1,030
Regulation of plasma-cell development
Shapiro-Shelef, M., & Calame, K. (2005) · Nature Reviews Immunology · doi:10.1038/nri1572 · Cited by 881
Self-citationShapiro-Shelef, M., Lin, K.-I., McHeyzer-Williams, L. J., Liao, J., McHeyzer-Williams, M. G., & Calame, K. (2003) · Immunity · doi:10.1016/s1074-7613(03)00267-x · Cited by 839
Self-citationThe Human Histone Deacetylase Family
Gray, S. G., & Ekström, T. J. (2001) · Experimental Cell Research · doi:10.1006/excr.2000.5080 · Cited by 546
Histone deacetylase inhibitors as new cancer drugs
Marks, P. A., Richon, V. M., Breslow, R., & Rifkind, R. A. (2001) · Current Opinion in Oncology · doi:10.1097/00001622-200111000-00010 · Cited by 531
Plasma Cell Ontogeny Defined by Quantitative Changes in Blimp-1 Expression
Kallies, A., Hasbold, J., Tarlinton, D. M., Dietrich, W., Corcoran, L. M., Hodgkin, P. D., & Nutt, S. L. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040973 · Cited by 531
Blimp1 associates with Prmt5 and directs histone arginine methylation in mouse germ cells
Ancelin, K., Lange, U. C., Hajkova, P., Schneider, R., Bannister, A. J., Kouzarides, T., & Surani, M. A. (2006) · Nature Cell Biology · doi:10.1038/ncb1413 · Cited by 464
Lin, K.-I., Angelin-Duclos, C., Kuo, T. C., & Calame, K. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.13.4771-4780.2002 · Cited by 445
Self-citationBlimp1 Defines a Progenitor Population that Governs Cellular Input to the Sebaceous Gland
Horsley, V., O'Carroll, D., Tooze, R., Ohinata, Y., Saitou, M., Obukhanych, T., Nussenzweig, M., Tarakhovsky, A., & Fuchs, E. (2006) · Cell · doi:10.1016/j.cell.2006.06.048 · Cited by 426
Saitou, M., & Yamaji, M. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008375 · Cited by 418
HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance
Campoli, M., & Ferrone, S. (2008) · Oncogene · doi:10.1038/onc.2008.273 · Cited by 404
Barnes, B. J., Moore, P. A., & Pitha, P. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101216200 · Cited by 388
Epigenetic Regulation of HIV-1 Latency by Cytosine Methylation
Kauder, S. E., Bosque, A., Lindqvist, A., Planelles, V., & Verdin, E. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000495 · Cited by 374
Regulation and Functions of Blimp-1 in T and B Lymphocytes
Martins, G., & Calame, K. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090241 · Cited by 372
Self-citationRegulatory Mechanisms that Determine the Development and Function of Plasma Cells
Calame, K. L., Lin, K.-I., & Tunyaplin, C. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141138 · Cited by 370
Self-citationInactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma
Pasqualucci, L., Compagno, M., Houldsworth, J., Monti, S., Grunn, A., Nandula, S. V., Aster, J. C., Murty, V. V., Shipp, M. A., & Dalla-Favera, R. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052204 · Cited by 370
Kurimoto, K., Yabuta, Y., Ohinata, Y., Shigeta, M., Yamanaka, K., & Saitou, M. (2008) · Genes & Development · doi:10.1101/gad.1649908 · Cited by 341
Vincent, S. D., Dunn, N. R., Sciammas, R., Shapiro-Shalef, M., Davis, M. M., Calame, K., Bikoff, E. K., & Robertson, E. J. (2005) · Development · doi:10.1242/dev.01711 · Cited by 337
Self-citationPRDI-BF1 recruits the histone H3 methyltransferase G9a in transcriptional silencing
Győry, I., Wu, J., Fejér, G., Seto, E., & Wright, K. L. (2004) · Nature Immunology · doi:10.1038/ni1046 · Cited by 334
Mäkelä, J.-A., Koskenniemi, J. J., Virtanen, H. E., & Toppari, J. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00140 · Cited by 327
Multifunctional role of the transcription factor Blimp-1 in coordinating plasma cell differentiation
Minnich, M., Tagoh, H., Bönelt, P., Axelsson, E., Fischer, M., Cebolla, B., Tarakhovsky, A., Nutt, S. L., Jaritz, M., & Busslinger, M. (2016) · Nature Immunology · doi:10.1038/ni.3349 · Cited by 322
Plasma cells: finding new light at the end of B cell development
Calame, K. L. (2001) · Nature Immunology · doi:10.1038/ni1201-1103 · Cited by 306
Self-citationRe-SET-ting heterochromatin by histone methyltransferases
Jenuwein, T. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)02001-3 · Cited by 302
Activation of MHC Class I, II, and CD40 Gene Expression by Histone Deacetylase Inhibitors
Magner, W. J., Kazim, A. L., Stewart, C., Romano, M. A., Catalano, G., Grande, C., Keiser, N., Santaniello, F., & Tomasi, T. B. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.12.7017 · Cited by 294
“Tissue specific expression of class I is determined, in significant part, by transcriptional mechanisms that depend on upstream negative regulatory elements in the class I promoter (45) and factors binding to these elements may recruit HDACs and repress transcription.”
BackgroundInfluentialPlasma cell development and survival
Oracki, S. A., Walker, J. A., Hibbs, M. L., Corcoran, L. M., & Tarlinton, D. M. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00940.x · Cited by 268
A tripartite transcription factor network regulates primordial germ cell specification in mice
Magnúsdóttir, E., Dietmann, S., Murakami, K., Günesdogan, U., Tang, F., Bao, S., Diamanti, E., Lao, K., Gottgens, B., & Azim Surani, M. (2013) · Nature Cell Biology · doi:10.1038/ncb2798 · Cited by 266
The prdm family: expanding roles in stem cells and development
Hohenauer, T., & Moore, A. W. (2012) · Development · doi:10.1242/dev.070110 · Cited by 265
The c‐myc Promoter: Still MysterY and Challenge
(2008) · Advances in Cancer Research · doi:10.1016/s0065-230x(07)99004-1 · Cited by 211
PRDM proteins: important players in differentiation and disease
Fog, C. K., Galli, G. G., & Lund, A. H. (2012) · BioEssays · doi:10.1002/bies.201100107 · Cited by 201
“(G9a H3K9me2 [9]) Yes [99] G9a [9], HDAC2 [13], IRF4 [100], LSD1 [15],”
BackgroundRombouts, K. (2002) · Experimental Cell Research · doi:10.1006/excr.2002.5577 · Cited by 111
Blimp‐1 induces and Hobit maintains the cytotoxic mediator granzyme B in CD8 T cells
Kragten, N. A. M., Behr, F. M., Vieira Braga, F. A., Remmerswaal, E. B. M., Wesselink, T. H., Oja, A. E., Hombrink, P., Kallies, A., van Lier, R. A. W., Stark, R., et al. (2018) · European Journal of Immunology · doi:10.1002/eji.201847771 · Cited by 91
Smith, J., & Davidson, E. H. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806442105 · Cited by 69
The FES Gene at the 15q26 Coronary-Artery-Disease Locus Inhibits Atherosclerosis
Karamanavi, E., McVey, D. G., van der Laan, S. W., Stanczyk, P. J., Morris, G. E., Wang, Y., Yang, W., Chan, K., Poston, R. N., Luo, J., et al. (2022) · Circulation Research · doi:10.1161/circresaha.122.321146 · Cited by 54
An epigenetically altered tumor cell vaccine
Khan, A. N., Magner, W., & Tomasi, T. (2004) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-004-0513-0 · Cited by 42
“this may be responsible for the failure of the tumors to express class II [13, 25].”
BackgroundEpigenetic regulation during melanocyte development and homeostasis
Dilshat, R., Vu, H. N., & Steingrímsson, E. (2021) · Experimental Dermatology · doi:10.1111/exd.14391 · Cited by 23
Metadata
- Authors
- Yu, J., Angelin-Duclos, C., Greenwood, J., Liao, J., & Calame, K.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2000-04
- Volume
- 20
- Issue
- 7
- Pages
- 2592-2603
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2122348846
- Cited by
- 327
- References
- 67
- FWCI
- 5.07
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.